Form 8-K - Current report:
SEC Accession No. 0000930413-20-002532
Filing Date
2020-11-16
Accepted
2020-11-16 17:03:45
Documents
13
Period of Report
2020-11-09
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 c100693_8kixbrl.htm   iXBRL 8-K 17346
  Complete submission text file 0000930413-20-002532.txt   154455

Data Files

Seq Description Document Type Size
2 enz-20201109.xsd EX-101.SCH 3312
3 enz-20201109_def.xml EX-101.DEF 10732
4 enz-20201109_lab.xml EX-101.LAB 21630
5 enz-20201109_pre.xml EX-101.PRE 11092
6 EXTRACTED XBRL INSTANCE DOCUMENT c100693_8kixbrl_htm.xml XML 2464
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

EIN.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 201318174
SIC: 8071 Services-Medical Laboratories